{"title":"Recent Articles in AATS Journals","authors":"","doi":"10.1053/j.semtcvs.2026.05.001","DOIUrl":"10.1053/j.semtcvs.2026.05.001","url":null,"abstract":"","PeriodicalId":48592,"journal":{"name":"Seminars in Thoracic and Cardiovascular Surgery","volume":"38 2","pages":"Pages e1-e5"},"PeriodicalIF":2.5,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148146709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Intraoperative Imaging and Localization Techniques","authors":"Yelizaveta Gribkova MD , Katherine D. Gray MD","doi":"10.1053/j.semtcvs.2025.05.010","DOIUrl":"10.1053/j.semtcvs.2025.05.010","url":null,"abstract":"","PeriodicalId":48592,"journal":{"name":"Seminars in Thoracic and Cardiovascular Surgery","volume":"38 2","pages":"Pages 147-152"},"PeriodicalIF":2.5,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144530496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lise N. Tchouta MD/MS , Lucy Nam MD , David A. D’Alessandro MD
{"title":"Looking to the Right Ventricle After Heart Transplantation: Invited Expert Opinion","authors":"Lise N. Tchouta MD/MS , Lucy Nam MD , David A. D’Alessandro MD","doi":"10.1053/j.semtcvs.2025.04.005","DOIUrl":"10.1053/j.semtcvs.2025.04.005","url":null,"abstract":"","PeriodicalId":48592,"journal":{"name":"Seminars in Thoracic and Cardiovascular Surgery","volume":"38 2","pages":"Pages 116-120"},"PeriodicalIF":2.5,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144053544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Leonardo Duranti MD, PhD, Luca Tavecchio MD, Luigi Rolli MD, Clarissa Uslenghi MD, Edoardo Ceruti MD, Michele Ferrari MD, Piergiorgio Solli MD
{"title":"Pediatric and Adult Telescopic Bronchial Sleeve Resections: Our 15 Years of Experience with Robot-Assisted, Video-Assisted and Open Surgery","authors":"Leonardo Duranti MD, PhD, Luca Tavecchio MD, Luigi Rolli MD, Clarissa Uslenghi MD, Edoardo Ceruti MD, Michele Ferrari MD, Piergiorgio Solli MD","doi":"10.1053/j.semtcvs.2025.08.008","DOIUrl":"10.1053/j.semtcvs.2025.08.008","url":null,"abstract":"<div><div>The bronchial sleeve represents a pivotal advancement in thoracic surgery, allowing for oncological radicality while preserving respiratory function. We present 29 cases of telescopic monofilament continuous suture bronchial sleeves out of a total of 43 bronchial sleeve resections performed by us. There were no mortalities, no bronchial positive margins, no local recurrences, and only one anastomotic fistula requiring pneumonectomy with open window thoracostomy, which closed after a few months (Fig. 2). The telescopic intussusception technique avoids the significant problem of caliber discrepancy, and this type of suture consolidates with the physiological increases in airway pressure due to Valsalva maneuver or coughing, because the internal “endobronchial” pressure generated is applied radially on the smaller caliber bronchus, pushing it and causing it to adhere to the larger caliber external bronchus.</div></div>","PeriodicalId":48592,"journal":{"name":"Seminars in Thoracic and Cardiovascular Surgery","volume":"38 2","pages":"Pages 133-138"},"PeriodicalIF":2.5,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145226139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nathan P. Zwintscher MD , Marc de Perrot MD , Marcelo Cypel MD, MSc , Shaf Keshavjee MD, MSc
{"title":"The Tempest Surrounding Lung Transplant for Lung Cancer, With Lung Cancer, or With Isolated Lung Metastases","authors":"Nathan P. Zwintscher MD , Marc de Perrot MD , Marcelo Cypel MD, MSc , Shaf Keshavjee MD, MSc","doi":"10.1053/j.semtcvs.2025.08.004","DOIUrl":"10.1053/j.semtcvs.2025.08.004","url":null,"abstract":"<div><div>Lung transplantation for cancer is controversial. The hesitancy has largely been driven by historical outcomes. However, early-stage lung cancer does not significantly affect the outcome of lung transplant for other end-stage lung diseases. We have also made more donor lungs available and hence can consider transplanting patients where the only curative option is to resect both lungs. With careful patient selection, experienced transplant centers can achieve acceptable long-term lung transplant results in patients with cancer as compared to those with other end-stage lung diseases. Additionally, there are two ongoing trials investigating the role of lung transplant for lung cancer and aim to expand access to lung transplants for cancer patients and potentially change medical opinion. If more than one type of patient can benefit from transplant, is it ethical to only allocate donor allografts to patients with chronic lung disease simply because that is what we have always done? Is one disease process more deserving of treatment than another?</div></div>","PeriodicalId":48592,"journal":{"name":"Seminars in Thoracic and Cardiovascular Surgery","volume":"38 2","pages":"Pages 171-175"},"PeriodicalIF":2.5,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145055964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Leonardo Duranti, Luca Tavecchio, Luigi Rolli, Piergiorgio Solli
{"title":"Systematic Review of Outcomes and Prognostic Factors of Pulmonary Metastasectomy for Various Primary Tumors.","authors":"Leonardo Duranti, Luca Tavecchio, Luigi Rolli, Piergiorgio Solli","doi":"10.1053/j.semtcvs.2026.04.002","DOIUrl":"10.1053/j.semtcvs.2026.04.002","url":null,"abstract":"<p><p>Pulmonary metastasectomy (PM) is a surgical procedure to remove lung metastases. Although it indicates advanced-stage disease, it is considered a therapeutic option to prolong survival in selected patients with oligometastatic disease, where lesions can be controlled locally. This systematic review synthesized the available evidence from reviews and retrospective studies on survival outcomes and prognostic factors associated with pulmonary metastasectomy (PM). A literature search was conducted in Ovid Medline, EMBASE, and the Cochrane Central Register of Controlled Trials covering the last 30 years up to January 2025, using the term \"pulmonary metastasectomy.\" Studies involving human subjects and published in English were included. Eighty two articles were reviewed. PM offers significant survival benefits across various tumor types, with 5-year survival rates varying widely (e.g., 35% to 72% for breast cancer and 40% to over 70% for colorectal cancer). Key favorable prognostic factors include: control of the primary tumor, absence or control of extrapulmonary metastases, complete resectability (R0), a long disease-free interval (DFI), and a limited number or size of metastases. However, most data comes from retrospective studies with potential selection bias. PM is considered a valid and potentially curative component of multimodal treatment strategies for resectable lung metastases. It requires rigorous patient selection and a multidisciplinary approach. Current limitations of the evidence (lack of randomized controlled trials, selection bias, high recurrence rates) highlight the need for further prospective research to optimize selection criteria and integrate PM with emerging systemic therapies.</p>","PeriodicalId":48592,"journal":{"name":"Seminars in Thoracic and Cardiovascular Surgery","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147934849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Preventing Stroke in Aortic Arch Operations.","authors":"Yuki Ikeno, Akiko Tanaka, Anthony L Estrera","doi":"10.1053/j.semtcvs.2026.04.001","DOIUrl":"10.1053/j.semtcvs.2026.04.001","url":null,"abstract":"<p><p>Progress in aortic arch surgery has paralleled advances in cerebral protection. Since DeBakey's first successful arch repair, neurologic complications have remained a major determinant of outcomes. The evolution of cerebral protection began with deep hypothermic circulatory arrest, followed by the reintroduction of antegrade cerebral perfusion and the development of retrograde cerebral perfusion. These strategies have collectively improved neurologic outcomes and expanded the safety margin for complex arch reconstruction. Despite these advances, stroke remains one of the most devastating complications after aortic arch repair, occurring in 5%-10% of contemporary cases and contributing to up to 50% mortality. Recent registries have demonstrated decreasing operative mortality-currently 3%-9%, depending on pathology. However, further refinements are needed. This review summarizes modern stroke-prevention strategies during aortic arch surgery, focusing on 4 key components: (1) Meticulous pre- and intraoperative neurologic assessment; (2) Optimized arterial cannulation and perfusion techniques; (3) Tailored degrees of hypothermia; and (4) Adjunctive cerebral perfusion methods. A comprehensive understanding and individualized application of these elements are essential in minimizing neurologic injury and further improving outcomes in contemporary aortic arch surgery.</p>","PeriodicalId":48592,"journal":{"name":"Seminars in Thoracic and Cardiovascular Surgery","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147786386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Commentary: The Price of Entry Reconsidered-The Promise of Nonintercostal Lobectomy.","authors":"Linda C Qu, Katherine D Gray","doi":"10.1053/j.semtcvs.2026.03.002","DOIUrl":"10.1053/j.semtcvs.2026.03.002","url":null,"abstract":"","PeriodicalId":48592,"journal":{"name":"Seminars in Thoracic and Cardiovascular Surgery","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147786445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Mid-and Long-Term Outcomes of Thoracic Endovascular with Branch Artery Revascularization in the Aortic Repair for Non-A Non-B Aortic Dissection.","authors":"Liwen Deng, Huanhuan Li, Wanli Yu, Xiangyi Zuo, Zichang Wang, Chunkai Wang, Li Meng, Lanxin Wen, Wanzhi Zeng, Yu Zhao, Xuehu Wang","doi":"10.1053/j.semtcvs.2025.12.001","DOIUrl":"10.1053/j.semtcvs.2025.12.001","url":null,"abstract":"<p><p>This study aimed to evaluate mid-and long-term outcomes of thoracic endovascular aortic repair (TEVAR) with individualized supra-aortic branch management strategies for acute/subacute non-A non-B aortic dissection. A retrospective cohort of 113 acute/subacute non-A non-B aortic dissection patients (January 2012-April 2024) was categorized into three groups based on endovascular techniques: non-revascularization (n=63), in-situ fenestration (n=22), and Ex-situ fenestration (n=28). The primary endpoint was all-cause mortality. Secondary endpoints included a range of follow-up aortic adverse events (AEs) and re-intervention during follow-up.Survival and risk factors were analyzed using Kaplan-Meier curves and Cox regression. The early outcomes demonstrated a high technical success rate of 96.5% with low 30-day mortality (0.9%). Endoleak patterns differed significantly between approaches, with type Ia endoleaks predominating in non-revascularization cases (36.5%) while ex-situ fenestration showed higher rates of type III endoleaks (50.0%). At a median follow-up of 45 months, all-cause mortality reached 15.7%, with the highest mortality observed in the in-situ fenestration group (22.7% vs. 3.7% for ex-situ fenestration and 18.4% for non-revascularization). The re-intervention rate was 15.6%, primarily addressing stent-induced new entry (SINE) or persistent endoleaks. Notably, ex-situ fenestration exhibited more favorable survival trends(3053 d(2833, 3276),p=0.13) and superior type III endoleak resolution (53.3%). Multivariate analysis identified age (HR=1.13, p=0.019) and thoracic aortic diameter (HR=1.126, p=0.002) as independent predictors of mortality. Thoracic endovascular aortic repair represents a safe and effective alternative to open repair for selected non-A non-B aortic dissection cases. While in-situ fenestration is associated with inferior long-term outcomes, particularly in anatomically challenging arches, ex-situ fenestration demonstrates favorable results despite higher initial type III endoleak rates, with most complications being self-limiting. The study underscores the importance of individualized technique selection and tailored antithrombotic therapy to mitigate cerebral hemorrhage risk.</p>","PeriodicalId":48592,"journal":{"name":"Seminars in Thoracic and Cardiovascular Surgery","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147575989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}